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Previous studies have demonstrated that platelet-
derived growth factor (PDGF) a receptor expression 
is up-regulated by transforming growth factor-J31 
(TGF-J31) in scleroderma dermal fibroblasts, but not 
in healthy control fibroblasts. We asked whether this 
selective effect in scleroderma cells was TGF-J3c 
specific or a general response by studying responses 
to other growth factors. In this study, we compared 
the expressit?n of a and J3 PDGF receptor subunits 
(mRNA and protein levels) in these two cell types in 
response to basic fibroblast growth factor (bFGF) and 
TGF-J31. bFGF coordinately stimulated mRNA levels 
of a and J3 receptor subunits in healthy fibroblasts, 
but did not change PDGF receptor expression in 
scleroderma fibroblasts. Conversely, and in agree-
ment with previous observations, TGF-J31 induced 
P latelet-derived growth factor (PDGF), a major smooth-muscle and fibroblast mitogen, exists as a dimer of homologous ·polypeptide chains, A and B . Heterodimer (PDGF AB) and homodimer (PDGF AA, PDGF BB) isoforms have been purifi ed &om natural sources and 
arc biologically active [1,2]. Two distinct PDGF receptor subunits, 
a and {3, have been identified, and a requirement for receptor 
dimerization for signa ling has been proposed [3- 6]. The rx receptor 
subunit binds all three isoforms of PDGF, whereas the {3 receptor 
subunit binds PDGF BB with high affillity and PDGF AB with low 
affinity; it does not bind PDGF AA [7]. Recent studies have 
indicated that other growth factors have the capacity to modulate 
proliferative responses to PDGF isoform s by affecting coordinately 
or selectively the expression of PDGF receptor subunits. For 
exampl e, PDGF BB up-regulatesPDGF C/ and {3 receptor expres-
sion in human foreskin fibroblasts [8], whereas o nly PDGF C/ 
receptor is up-regulated by interieukin-1 in osteoblasts [9], by basic 
fibroblast growth factor (bFGF) in smooth-muscle cells [10], or by 
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PDGF a receptor expression in scleroderma fibro-
blasts, but not in healthy fibroblasts. PDGF J3 recep-
tor mRNA levels were induced to similar degrees by 
TGF-J31 in both cell types. PDGF a receptor protein 
levels correlated directly with mRNA levels, induced 
by bFGF only in healthy fibroblasts and by TGF-J31 
only in scleroderma fibroblasts. However, PDGF J3 
receptor protein levels were not altered by either 
growth factor in either cell type. Thus, the activated 
state of scleroderma fibroblasts do~s not include 
receptor-signaling pathways to bFGF. This distinct 
pattern of expression of PDGF a receptors in sclero-
derma fibroblasts suggests a possible role for the 
coordinately expressed PDGF AA ligand/a receptor 
system in the development of fibrosis. ] Invest Derllla-
tol 104:124-127, 1995 
thrombin in human lung fibroblasts [11]. Transforming growth 
factor-{3 (TGF-{3) down-regulates expression of PDGF a receptor 
in several cell types including foreskin fibroblasts, smooth-muscle 
ceLIs, chondrocytes, and NIH 3T3 cells [12,13] , but up-regulates 
the expression of PDGF (3 receptors in NIH 3T3 cell s [13]. In 
addition, it was shown recently that down-regulation of PDGF a 
receptors by TGF-{3 in foreskin fibroblasts is dependent on cell 
density [14]. 
Dernlal fibroblasts isolated from the involved skin of sclerodernla 
(SSc) patients exhibit a distinct phenotype characterized by elevated 
expression of extracellular matrix mRNAs [15-20] and alterations in 
proliferative responses to several growth factors [21-23]. We have 
demonstrated previously that regulation ofPDGF a receptor expres-
sion in response to TGF-{3 J differs between SSc and healthy human 
fibroblasts [22]. TGF-{3J causes up-regulation of PDGF C/ receptor 
levels in SSc fibroblasts, whereas in heald1y adult fibroblasts, PDGF a 
receptor levels are either slightly inhibited or not affected by TGF-{3J. 
In agreement with another report [12], we found significant down-
reguJation of PDGF C/ receptors by TGf-{3, in newborn foreskin 
fibroblasts [22] . Proliferative responses of tllese three cell types to 
PDGF AA after pretreatment with TGF-{3J cOlTelated with tile effects 
on PDGF a receptor expression: an increased response in SSc fibro-
blasts, small changes in response in heald1y adult fibroblasts , and a 
significant decrease in newborn foreskin fibroblasts. 
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Figure 1. Effects of various growth factors on PD.GF a and f3 
mRNA levels in newborn foreskin fibroblasts. Cells were grown, 
stimulated with TGF-f3, (1 ng/ml), PDGF AA (10 ng/ ml) , PDGF BB (10 
ng/ml) , T NF-Cl' (10 ng/ml), or bFGF (10 ng/ml). and analyzed by Northern 
blot as described in the text. 
W e and others also have demonstrated th at SSc fibroblasts show 
decreased prolife rative respon ses to bFGF when compare d to 
normal fibroblasts [23]. Furthe rmore, TGF-{31 pretreatment in-
creased mitogenic responses syne rgistica ll y to bFGF in normal 
fibroblasts, but not in SSc fibroblasts. These difFe re n ces are n o t 
relate d to e ither bFGF receptor number o r affinity; both cell types 
possess similar con stitutive numbers of h.ig h- and low-affinity 
receptors [23]. 
In the present study, we examine d the efFects of TGF-{3, and 
bFGF 011 the express ion of PDGF a and (3 receptor mRNA and 
prote in levels in SSc and in healthy d e rma l fibrob lasts. Our data 
show a complex patte m of reg ulation ofPDGF receptor subunits by 
these two growth factors, with distinct dill"eren ces be tween SS c and 
healthy fibrobl asts . 
MATERI ALS AND METHODS 
Cells Scleroderma and healthy skin fibroblasts were obtained and prop-
agated as dcsuibed previously (22). Fibroblasts in the th.ird and fourth 
subpassages were used for experim ents. For eva luation of the response to 
cytokines, cell s were deprived of serum in Dulbecco 's modification of 
Eagle's medium for 48 h before growth-factor addi tion. 
Growth Factors and Antibodies bFGF was purchased from R &D 
System Inc. (Minneapolis. MN) and TGF-f3 , fi'om GIBCO BRL (Grand 
Island, NY) . PDGF AA , PDGF BB, tumor necros is f.,ctor-Cl' (TNF-Cl'), and 
polyclona l anti-PDGF A receptor or -PDGF B receptor antibodies were 
from Ul3l (Lake Placid , NY) . 
RNA Preparation and Northern Blot Analysis Total RN A was 
ex tracted using an acid guanidinium thiocyanate-phenol chloroform 
method [24 J. Ten micrograms of total R.NA was subjected to electrophore-
sis on 1 % aga rose formaldehyde gel and blotted to nylon filters (lC N 
Biochemica ls Inc .. C leveland, O Hi o T he filters were cross- linked b), 
ul traviolet irrad iation using a Strata linker (Stratagene. La Jolla, CAl. 
Conditions of hybridization and washing were as described [25]. Filters 
were first quantitated using Phosphoimager (Molecular Dynamics. Sunny-
vale, CAl , then were exposed to Kodak X-Olilat AR film at - 70°C for 
several da)'s and processed by autoradiography. Preparation of the probes 
(PDGF Cl' receptor, kindly provided by S. Aaronson; PDGF f3 receptor and 
glyceraldehydc-3-phosphate dehydrogenase IGAPDH] . obtained from 
Am erican Type C ulture Collection) was as described previousl), [25]. Filters 
were hybridized sequentia lly with PDGF Cl' receptor, PDGF f3 receptor, and 
GAPDJ-I probes. Relative intensity of the signal with each probe was 
quantitated using Phosphoimager. SSc and healthy human adult fi broblast 
RNA samples were always analyzed together. 
Immunoblotting Cell extracts were prepared and Western blot ana lysis 
was perfo rmed as described previously [11 J. All samples were separated by 
sodium dodecylsulfate-polyacrylamide gel electrophoresis on G% Laemmli 
ge ls and transferred to Ititrocellulose membranes. Blots were blocked and 
then probed with the respective p";mary :lI1tibodies at appropriate dilutions. 
foll owed b)' incuba tion with peroxidase-conjugated goat anti-rabbi~ IgG 
antibody (Org'1I10n Teknika Corp .. Durham, NC). Blots were developed 
using the ECL system (Amersham Corp., Arlington Heights. IL) . 
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Statistical Methods Data were analyzed using the INSTAT 2 statistics 
package (Graph Pad. Software. Sail Diego, CAl. Comparisons of PDGF Cl' 
and f3 receptor ml~A expression in response to bFGF were made between 
stimulated and nonstimulated ce ll s using one-way analysis of variance with 
correction for multiple comparisons by the Dunnett multiple comparison 
test. 
RESULTS 
In the initial expe riments, we tested the effects of several growth 
factors, including PDGF BB, PDGF AA, b FGF, TGF-{3 , , and 
T NF-a, on the expressio n of PDGF a and {3 receptors in human 
fibroblasts. The mRN A levels of PDGF 0' and {3 receptors were 
analyzed in confluent, serum-deprived cells stimulated fo r 3 h or 8 
h with individual g rowth factors . Several cell lines of n ewbom 
foreskin fibroblasts and h ealth y dermal skin fibroblasts were used 
for the initial experim ents. Although difFerences were observed in 
the magnitude of respon ses between individual cell lines, the 
m odu lation of expression of PDGF a and {3 receptors by different 
g rowth factors was similar in newborn foreskin and adult skin 
fibroblasts. A re presentative example of the Northern blot analysis 
in foreskin cells is shown in Fig 1. T he strongest effects were 
obse rved with bFGF, w hich stimulated mRNA expression levels of 
both PDGF receptors; thert;!fore bFGF was chosen for further 
analysis in SSc and h ealthy fibroblasts. As re ported previously [8], 
PDGF AA and PDGF BB stimulated PDGF {3 receptor mRNA 
expressio n but h ad little effect o n mRNA expression of PDGF a 
receptors. TGF-{3 , inhibited express ion ofPDGF a receptors while 
slig htly stimulating expressio n ofPDGF {3 receptors. TNF-a inhib-
ited PDGF {3 receptor expressio n w ith out affectin g PDGF 0' 
receptor mRNA le ve ls. 
Four pairs of SSc and control h ealth y fibroblasts were stimulated 
with increasing doses of bFGF (1-25 n g/ml) and analyzed for 
mRNA le vels of PDGF a and {3 receptors (Fig 2). In healthy 
fibroblasts, 5 ng/ ml maximally sti mulated PDGF 0' receptor 
mRNA levels, whereas 1 ng/ ml o fbFGF was suffi cien t to stimulate 
maximally PDGF {3 receptor mRNA levels. In contrast, n either 
PDGF a nor {3 receptors were induced by bFGF in SSc fibrob lasts. 
We n ext compared the time course ofbFGF e ffects o n PDGF a 
and {3 receptor mRNA levels in SSc and healthy fibroblasts (Fig 3). 
In healthy fibroblasts, stimulato ry effects ofbFGF could be detected 
afte r 1 h of treatment, and m aximal effects o n both receptor types 
were seen after 8 h . PDGF a receptor mRNA levels declined 
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Figure 2. bF GF stimulates PDGF a and f3 receptor mRNA levels in 
healthy fibroblasts, but not in SSe fibroblasts. Cells were stimulated 
with the indicated concentrations ofbFGF and analyzed b)' Northern blot as 
described in the text. Quantitative analysis (mean :!: standard deviation) is 
presented of PDGF Cl' receptor levels (n) and PDGF f3 receptor levels (b) in 
fo ur pairs of SSc (solid bm:,) and normal dermal fibrob lasts (sl/Oded bnrs). 
Density of the band in the control lanes (0 bFGF) for each SSc and normal 
cell line was set at 100. Values frO I11 the bFGF-treated cells indicate band 
density relati ve to control. All values were corrected fo r the loading 
differences, as determined by GAPDl-I mRN A intensity. Statistically signif-
icant results: • p < 0.05; ** P < 0.01. 
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Figure 3. Time course of the bFGF effects on PDGF ll' and f3 
receptor mRNA levels in SSc and healthy fibroblasts. Cells were 
stimulated with bFGF (10 llg/ ml) for 1, 3, 8, and 24 h and analyzed by 
Northern blot as described in the text. Quantitative analysis (mean :!: 
standard deviation) is presented ofPDGF a receptor levels (a) and PDGF {3 
receptor levels (b) in four pairs of SSc (solid circles) and normal dermal 
fibroblasts (opell circles). * p < 0.05; •• P < 0.01. 
remained elevated after 24 h of incubation. In SSc fibroblasts, bFGF 
had no effect on either PDGF receptor type in the 24 h tested . 
Western blot ana.lysis of the expression of PDGF ex and /3 
receptor proteins after bFGF treatment correlated only partially 
with mRNA levels. PDGF ex receptor protein was strongly induced 
in healthy fibroblasts after 24 h of treatment, and e levated levels 
persisted up to 72 h (Fig 4). In SSc fibroblasts, slight induction of 
PDGF ex protein levels appeared only after 72 h . In contrast, PDGF 
/3 receptor protein levels were not affected by bFGF treatment in 
either ceU type. 
We have reported previously the effec ts ofTGF-/3, on PDGF ex 
receptor expression in SSc and healthy fibroblasts (22); however, 
the effects of TGF-/3, on PDGF /3 receptor expression have not 
been examined previously. Two pairs ofSSc and healthy fibroblasts 
were stimulated with 1 ng/m l of TGF-/3, for 3 h or 8 hand 
analyzed for mRNA expression of PDGF ex and /3 receptors. [n 
agreement with previous observations, TGF-/3, increased PDGF ex 
receptor mRNA levels in SSc fibroblasts but had 110 effect on, or 
even slightly decreased, PDGF ex receptor levels in healthy fibro-
blasts (Fig 5). PDGF /3 receptor mRNA levels were similarly 
induced in SSc and healthy fibroblasts. 
We also examined the effects of TGF-/3, 011 PDGF ex and /3 
receptor protein in SSc and healthy fibroblasts. As shown in Fig 6, 
PDGF ex receptor protein levels were induced by TGF-/3, in SSc 
fibroblasts and decreased in h ealthy fibroblasts; however, PDGF /3 
receptor protein levels remained wlchanged after TGF-/3, treat-
ment in both ceU types. 
The effects ofbFGF and TGF-/3, on PDGF receptor mRNA and 
protein levels in SSc and healthy fibroblasts are summarized in 
Table I. 
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Figure 4. bFGF increases PDGF ll' receptor protein levels i.n 
healthy fibroblasts without affecting PDGF f3 receptor. Confluent 
cells were stimu lated with bFGF (10 ng/ml) for 24, 48, and 72 h and 






















Figure 5. Effects of TGF-f3, on PDGF IX and f3 receptor mRNA 
levels in SSc and healthy fibroblasts . Cells were stimulated with 
TGF-{3, (1 ng/ ml) for 3 h and 8 h and analyzed by Northern blot as 
described in the text. Quantitative ana lysis (mean :!: standard deviation) is 
presented ofPDGF ex receptor levels (a) and PDGF {3 receptor levels (b) in 
two pairs of SSc (~olid hal'S) and normal dermal fibroblasts (shaded bars). 
Results were quanntated as described in the Fig 2 legend. Statistics were 
not performed because only two pairs were studied. 
DISCUSSION 
The regu lation of expression ofPDGF ex and (3 receptor subunits by 
bFGF and TGF-/31 is distinctly different betwee,n SSc and healthy 
fibrob lasts. An additional complexity is the lack of correlation 
between these effects at the mRNA and protein levels. 
Stimulatory effects of bFGF on PDGF receptor expression in 
healthy fibroblasts, but not in SSc fibroblasts, agree with previous 
observations of decreased proliferative responsiveness of SSc fibro-
blasts to bFGF [21,23] . Thus, in hea lthy 11lIman fibroblasts, bFGF is 
a potent direct mitogen 311d in addition may increase mitogenic 
responses to PDGF via induction of PDGF receptors. In contrast 
these eHects ofbFGF are absent in SSc fibroblasts. We have found 
recently that bFGF is equaUy potent in inhibiting coUagen ex2(1) 
mRNA levels in SSc and healthy fibroblasts " . Taken together with 
the previous observation of similar bFGF receptor numbers and 
affinities in SSc and healthy fibrobhists (23), these data suggest that 
different post-receptor-signaling pathways may be involved in 
proliferation and matrix regu lation by bFGF and that only prolif-
erative pathways are altered in SSc fibroblasts. Scleroderma 311d 
healthy fibroblasts may be useful in mapping these different signal-
transduction pathways. 
Although PDGF ex receptor protein le vels correlated with 
mRNA levels and were induced by bFGF in healthy d ermal 
fibroblasts and by TGF-/3 , in SSc fibroblasts, PDGF /3 receptor 
• Ichilci Y, Smith EA, LcRoy EC, Trojanowska M: Basic FGF inh.ibits 
collagen a2(1) gene expression in scleroderma and normal fibroblasts. 
(Submitted). 
-NS -sSe 
... a receptor 
... IJ receptor 
Figure 6. TGF-f3, increases PDGF ll' receptor protein levels in SSc 
fibroblasts without affecting PDGF f3 receptor. Cells werc stim ulated 
with TGF-{3, (1 ng/ ml) or with ,bFGF (10 ng/ml) for 24 h and analyzed by 
Western blot as described in Materials mid Methol/.!. NS, norma l dermal 
fi broblasts. 
... 
VOL. 104. NO. J ANUAR Y 1995 b FGF UPlliGULATES PDGFItA IN SKIN FIB R OB LASTS 127 
Table I. SSc and Healthy Fibroblasts Differ in the Effects ofbFGF and TGF-f3, on PDGF O! and f3 Receptors 
SSe Normal Fibroblasts 
POC F a R eceptor POCF f3 R eceptor POC F a R ecepto r POCF f3 R eceptor 
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prote in levels were no t changed after either growth-.f:JC tor treat-
m ent in either cell type . T h.i s findin g sugges ts a mo re stringent 
regulation at the post-transcriptionallevel(s) . One possibili ty is th at 
PDGF f3 recepto r levels are already m a)";mal, as adul t fibro blasts 
cultured on pl asti c express 10-20-fo ld higher levels o f PDGF f3 
receptor than a recepto r [7]; another possibili ty is that more than 
one stimulus (e.g. , two or more fa ctors) is required for th e 
induction of PDGF f3 receptors at the post-transcriptio nal level. 
Because there i.s a lack of correlation o f PD G F f3 receptor mRNA 
and protein levels, interpretation o f these results and their relevan ce 
to the ;11 lIi llo si tua tio n is uncertain. III II;VO, fibroblasts do not 
express or express low levels of PDG F f3 recepto rs [26], but 
increased expression o f PDGF f3 receptors was observed in several 
ch.ronic inflammatory disorders [27,28] , including SSc les ions [29]. 
T GF-f3, and bFGF also have been detected in these lesions [3 0,3 1]; 
whether either contributes to the increased PDGF f3 receptor 
expression ;1/. II ; VO rem ains to be established . 
In conclusion, this study demo nstrates distinct differences in 
regula tion of PDG F a receptor mRN A and prote in expressio n by 
bFGF and TG F-f3, in SSc and healthy adul t fibrobla sts. T he 
reason(s) fo r these difFe rent patte rns of PDG F receptor gene 
expression currently are unknown . T hey m ay be related to the 
differences in signaJ-transduction path ways media ted by TGF- f3 , 
and bFGF in SSc and hea lthy fibrobl as ts, or to diKerences in the 
levels o r activities o f transcription factors involved in regulating the 
PDGF a recepto r gene in these two cell typ es. T hese possibilities 
will be tes ted in future studies. 
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